Anton Buchner

The Gastrointestinal Tolerability of the LOX/COX Inhibitor, Licofelone, is Similar to Placebo and Superior to Naproxen Therapy in Healthy Volunteers: Results From a Randomized, Controlled Trial

Peter Bias, Anton Buchner, Bernhard Klesser et al. · The American Journal of Gastroenterology · 2004 · 90 citations

Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

Igor Bondarenko, Oleg Gladkov, Reiner Elsaesser et al. · BMC Cancer · 2013 · 89 citations · Full text

A randomized, double-blind, active control, multicenter, dose-finding study of lipegfilgrastim (XM22) in breast cancer patients receiving myelosuppressive therapy

Anton Buchner, Reiner Elsässer, Peter Bias · Breast Cancer Research and Treatment · 2014 · 35 citations · Full text

Dose-finding Study, Breast Oncology, Oncology +12

Efficacy and Safety of Balugrastim Compared With Pegfilgrastim in Patients With Breast Cancer Receiving Chemotherapy

Constantin Volovăț, Oleg Gladkov, Igor Bondarenko et al. · Clinical Breast Cancer · 2013 · 26 citations

Breast Oncology, Oncology, Medicine +7

Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy

Constantin Volovăț, Igor Bondarenko, Oleg Gladkov et al. · SpringerPlus · 2015 · 23 citations · Full text